Article Information
vol. 49 no. 3
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 14, 2016
- Accepted December 20, 2016
- Published online March 15, 2017.
Copyright & Usage
Copyright ©ERS 2017
Author Information
- Angira Dasgupta1,
- Melanie Kjarsgaard1,
- Dante Capaldi2,
- Katherine Radford1,
- Fernando Aleman1,
- Colm Boylan3,
- Leonard C. Altman4,
- Thomas N. Wight5,
- Grace Parraga2,
- Paul M. O'Byrne1 and
- Parameswaran Nair1⇑
- 1Dept of Medicine, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada
- 2Robarts Research Institute, Western University, London, ON, Canada
- 3Radiology, McMaster University & St Joseph's Healthcare, Hamilton, ON, Canada
- 4University of Washington, Seattle, WA, USA
- 5The Matrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA
- Parameswaran Nair, Firestone Institute for Respiratory Health, St Joseph's Healthcare, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada. E-mail: parames{at}mcmaster.ca
Funding
GlaxoSmithKline
Canada Research Chair program
Article usage
Altmetrics
Vol 49 Issue 3
Table of Contents
A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis
Permalink:
